ArticleOncology letters2018

Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway.

Xinxin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.